Product Information
AVAPRO 300 MG TABLET is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $8.8036 per EA under NDC 00024585230. Its NADAC has been published 648 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the irbesartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024585230
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
New Drug (NDA)
FDA Application
NDA020757On Market Since
1/1/2013
Pharmacological Classes
Price Statistics
The NADAC for AVAPRO 300 MG TABLET has been published 648 times since Nov 28, 2013, and over the history we have for it it has risen 114.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8036 per EA |
|---|---|
| All-time high | $8.8590 (May 15, 2024) |
| All-time low | $4.0874 (Jan 22, 2014) |
| 52-week high | $8.8209 |
| 52-week low | $8.7975 |
| Median price | $7.6301 |
| Average price | $7.3328 |
| Largest weekly change | +10.0% (Nov 5, 2014) |
| Weeks tracked | 648 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the irbesartan market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AVAPRO 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AVAPRO 300 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $8.8036 per EA (NDC 00024585230), effective Jun 24, 2026.
How has the price of AVAPRO 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for AVAPRO 300 MG TABLET has risen 114.6%. It has been tracked across 648 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AVAPRO 300 MG TABLET?
Since Nov 28, 2013, the NADAC for AVAPRO 300 MG TABLET has ranged from a low of $4.0874 (Jan 22, 2014) to a high of $8.8590 (May 15, 2024), with a median of $7.6301 per EA.
Are there cheaper alternatives to AVAPRO 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AVAPRO 300 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures AVAPRO 300 MG TABLET?
AVAPRO 300 MG TABLET (NDC 00024585230) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification